P&G Health Care Outshines Other Segments In Q2
Executive Summary
The Procter & Gamble Company reported that its health care segment advanced 5% (7% organically) on the strength of innovations in oral care and personal health. The firm’s organic sales increase of 2% in the quarter surpassed analyst expectations.
You may also be interested in...
P&G Keeps Direct-to-Consumer In Perspective, Retail Distribution Primary
Procter & Gamble remains focused on conventional retail sales, though it will continue to leverage the DTC distribution channel for several categories, CFO Jon Moeller says. Health care sales in the firm's latest quarter jumped 7%, outperforming other sectors.
P&G To Cut Portfolio In Half, Refocus On Core In Simplification Strategy
P&G will divest or discontinue half its brands and focus on lines that account for 90% of its total sales under a streamlining effort CEO A.G. Lafley says will result in portfolio offering “consumer-preferred and customer supported” products.
IFF Narrows Focus To Fragrance, Health, Food
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value of $2.85bn to reduce debt and streamline its business to three segments, including scents.